These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34142207)

  • 1. Plague vaccines: new developments in an ongoing search.
    Rosenzweig JA; Hendrix EK; Chopra AK
    Appl Microbiol Biotechnol; 2021 Jun; 105(12):4931-4941. PubMed ID: 34142207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
    mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing live vaccines against plague.
    Sun W; Roland KL; Curtiss R
    J Infect Dev Ctries; 2011 Sep; 5(9):614-27. PubMed ID: 21918302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational considerations about development of live attenuated Yersinia pestis vaccines.
    Sun W; Curtiss R
    Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges in the development of vaccines for pneumonic plague.
    Smiley ST
    Expert Rev Vaccines; 2008 Mar; 7(2):209-21. PubMed ID: 18324890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Bowen W; Batra L; Pulsifer AR; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2019 Sep; 37(38):5708-5716. PubMed ID: 31416643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C; McCormick AA; Arnaboldi PM
    Vaccine; 2021 Mar; 39(9):1435-1444. PubMed ID: 33531196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia pestis (plague) vaccines.
    Titball RW; Williamson ED
    Expert Opin Biol Ther; 2004 Jun; 4(6):965-73. PubMed ID: 15174978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
    Tao P; Mahalingam M; Zhu J; Moayeri M; Sha J; Lawrence WS; Leppla SH; Chopra AK; Rao VB
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327445
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
    Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries.
    Cui Y; Yang X; Xiao X; Anisimov AP; Li D; Yan Y; Zhou D; Rajerison M; Carniel E; Achtman M; Yang R; Song Y
    Infect Genet Evol; 2014 Aug; 26():172-9. PubMed ID: 24905600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.